Our Transformation to Lumara Health
Previously known as KV Pharmaceutical Company/Ther-Rx Corporation, Lumara Health is focused on offering quality healthcare that advances patient care. Find out more about who we are and what we stand for.
Learn more about our new leadership team and how we are bringing new expertise to help us become a leader in women’s healthcare.
A commitment to the fight against prematurity
In the United States, one in nine babies are born too early (<37 weeks gestation)¹. We believe that even one baby born too early is too many. There is still work to be done to lower the number of premature births. We are dedicated to doing our part in reducing the prematurity rate through collaboration with healthcare providers to advance patient care, research and development, and collaborative community educational initiatives.
Lumara Health Announces Available Research Grants in Prematurity
Lumara Health invites researchers to submit proposals for research grants in prematurity including new clinical strategies for reducing preterm birth and identifying high-risk women early in their pregnancies to ensure they seek appropriate healthcare.
A Focus On Quality
We’re passionate about delivering important, quality products to our patients and their healthcare providers. Our portfolio of FDA-approved products provides patients confidence that they are receiving high quality, safe and effective treatments.
Making A Meaningful Difference
For Our Patients
Every week counts during a
pregnancy – each week the baby is reaching critical developmental
milestones. When Kate faced a second high risk pregnancy and the risk of delivering preterm again, she and her physician turned to a trusted, FDA-approved product.
Lumara Health™ to be Acquired in Two Separate Transactions for up to $1.107 Billion
September, 29, 2014
K-V Pharmaceutical Company today announced a new corporate name, Lumara Health Inc.
May, 29, 2014
Pharmaceutical Executive Paul Williams Joins K-V Pharmaceutical Company as Head of Women’s Healthcare Division
May 9, 2014
K-V Pharmaceutical Company Appoints Healthcare Veteran, Gregg Raybuck, to Lead New Maternal Health Division
February 21, 2014